Bill of Health

OCTOBER 26, 2023

By Kayum Ahmed, Julia Bleckner, and Kyle Knight In mid-May, the World Health Organization officially declared the “emergency” phase of the COVID-19 pandemic over. Public health emergencies aren’t entirely preventable. Solidarity operates at two intersecting levels.

COVID-19 303

COVID-19 Public Health Pharmaceutical Industry World Health 303

Dot Compliance

FEBRUARY 13, 2025

The World Health Organization (WHO) has established guidelines for BMRs to ensure consistency, quality, and safety across the global pharmaceutical industry. By following these guidelines, manufacturers can: Protect public health: Ensure that the products they produce are safe and effective for use.

Pharmaceutical Industry 59

Pharmaceutical Industry Regulatory Compliance Public Health Compliance 59

Bill of Health

DECEMBER 12, 2023

By Tara Davis and Nicola Soekoe In January 2021, the Director General of the World Health Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19 vaccines. States can no longer pretend not to know this.

COVID-19 Vaccine 147

COVID-19 Vaccine COVID-19 Public Health Pharmaceutical Industry 147

Bill of Health

AUGUST 29, 2022

Importantly, most of the commitments made under the Open COVID Pledge were designed to expire at the end of the COVID-19 pandemic as determined by the World Health Organization (WHO) or January 1, 2023, whichever occurs first (the 2023 date is now in the process of being extended). Moderna’s Pledge. From 2020 to 2022, the U.S.

COVID-19 Vaccine 362

COVID-19 Vaccine COVID-19 Licensing Governance 362

Bill of Health

JULY 11, 2024

by Daniela Cepeda Cuadrado There is a wealth of research demonstrating that corruption — the abuse of entrusted power for private gain — has contributed to weakening health systems and worsening public health globally. Yet, funding for mental health is grossly inadequate. The industry gave more than $14.2

Pharmaceutical Industry 157

Pharmaceutical Industry COVID-19 Doctors Licensing 157

SQA

JUNE 3, 2024

Now the Ministry of Health has published revised regulations in accordance with Annex M of the Drugs and Cosmetics Rules. Now the Ministry of Health has published revised regulations in accordance with Annex M of the Drugs and Cosmetics Rules.

FDA 40

FDA COVID-19 Licensing Nurses 40

SQA

FEBRUARY 26, 2024

It provides a practical guide for the pharmaceutical industry on how to implement PACs within the framework of an effective Pharmaceutical Quality System (PQS) and in alignment with ICH quality guidelines. Schedule 10 lists substances of such danger to public health as to warrant their prohibition from supply and use.

FDA 52

FDA Compliance COVID-19 Public Health 52